Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events.

BACKGROUND The use of drugs with anticholinergic adverse effects is often deemed inappropriate in elderly (aged > or = 65 years) patients, yet studies continue to show extensive use in this population at high risk for adverse drug events (ADEs). The burden of drug-related anticholinergic symptoms in community-dwelling elderly patients has not been well described. OBJECTIVE The aim of this study was to assess the prevalence of anticholinergic symptoms, corresponding symptom burden, and anticholinergic-related ADEs in a sample of community-dwelling elderly veterans. METHODS This prospective cohort study was conducted at the primary care clinics at the Veterans Affairs Medical Center (VAMC), Iowa City, Iowa. The study sample included randomly selected patients with intact cognitive function attending the VAMC and prescribed > or = 5 scheduled medications. Data on current prescription and nonprescription drug use were elicited by a trained research assistant and a clinical pharmacist from patient interviews and electronic medical records. The prevalence and severity of 7 anticholinergic symptoms (dry mouth, constipation, blurred vision, confusion, urinary hesitation, dry eyes, and drowsiness) were assessed at baseline. The occurrence of ADEs at 12 weeks was compared between patients using anticholinergic drugs and those not using them. RESULTS A total of 532 patients were included (97.9% men; mean age, 74.3 years; 27.1% used at least 1 anticholinergic drug). Twenty-two anticholinergic drugs (16 prescription medications, 6 over-the-counter medications) were identified. The mean number of anticholinergic symptoms was significantly higher in the group using anticholinergic drugs (3.1 vs 2.5; P < 0.01). However, only 2 symptoms were statistically more prevalent in the group using anticholinergic drugs: dry mouth (57.6% vs 45.6%) and constipation (42.4% vs 29.4%) (both, P < 0.01). At 12 weeks, only 1 (0.8%) patient in the group using anticholinergic drugs reported an ADE considered related to an anticholinergic drug. CONCLUSIONS Anticholinergic drug use was common (27.1%) in these elderly veterans with intact cognitive function. The mean number of anticholinergic symptoms was significantly greater in this group, and the prevalences of dry mouth and constipation were significantly higher in the group using anticholinergic drugs (all, P < 0.01). Anticholinergic-related ADEs were rare (0.8%). Although anticholinergic drugs should generally be avoided in the elderly, individual risks and benefits for a patient should be considered.

[1]  N. Laird,et al.  Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .

[2]  L. Tune Anticholinergic effects of medication in elderly patients. , 2001, The Journal of clinical psychiatry.

[3]  H. Dodge,et al.  Sedative-hypnotic use of diphenhydramine in a rural, older adult, community-based cohort: effects on cognition. , 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[4]  S. O’Keeffe,et al.  Drug-Induced Cognitive Impairment in the Elderly , 1999, Drugs & aging.

[5]  J. Dartigues,et al.  Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study , 2004, European Journal of Clinical Pharmacology.

[6]  L. Tune,et al.  Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease. , 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[7]  J. Hanlon,et al.  Inappropriate Drug Use Among Community‐Dwelling Elderly , 2000, Pharmacotherapy.

[8]  J. Ware,et al.  How to score and interpret single-item health status measures: a manual for users of the SF-8™ Health Survey. , 2001 .

[9]  Lesley H Curtis,et al.  Inappropriate prescribing for elderly Americans in a large outpatient population. , 2004, Archives of internal medicine.

[10]  H. Scher,et al.  The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. , 1994, European journal of cancer.

[11]  P. Kaboli,et al.  The Va Enhanced Pharmacy Outpatient Clinic (epoc) Study: A Randomized-controlled Pharmicist-physician Intervention Trial , 2004 .

[12]  B. Pollock,et al.  Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. , 2003, Archives of general psychiatry.

[13]  R B Wallace,et al.  Self-Reported Adverse Drug Reactions and Related Resource Use , 1992, Annals of Internal Medicine.

[14]  R. Turnbull,et al.  Xerostomia: clinical aspects and treatment. , 2003, Gerodontology.

[15]  Regulatory Issues in Vascular Dementia: A European Perspective , 2003, International Psychogeriatrics.

[16]  J. Hanlon,et al.  Use of Inappropriate Prescription Drugs by Older People , 2002, Journal of the American Geriatrics Society.

[17]  C. Raehl,et al.  Methods for Assessing Drug‐Related Anticholinergic Activity , 2005, Pharmacotherapy.

[18]  D. Kiely,et al.  The association of serum anticholinergic activity with delirium in elderly medical patients. , 1998, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[19]  M. Abrahamowicz,et al.  Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. , 2001, Archives of internal medicine.

[20]  M. Folstein,et al.  The Mini-Mental State Examination. , 1983, Archives of general psychiatry.

[21]  E. Pfeiffer A Short Portable Mental Status Questionnaire for the Assessment of Organic Brain Deficit in Elderly Patients † , 1975, Journal of the American Geriatrics Society.

[22]  Abraham Weizman,et al.  Anticholinergic Burden and the Risk of Falls Among Elderly Psychiatric Inpatients: A 4-Year Case-Control Study , 2002, International Psychogeriatrics.

[23]  M. Beers,et al.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. , 2003, Archives of internal medicine.

[24]  N. Laird,et al.  Incidence of adverse drug events and potential adverse drug events , 1995 .

[25]  J. Delafuente,et al.  Therapeutics in the Elderly , 1995 .

[26]  M. Tinetti,et al.  Drugs and Falls: Rethinking the Approach to Medication Risk in Older Adults , 2002, Journal of the American Geriatrics Society.